anmelden
OMX Nordic 40
2.616,70
PKT
+0,46
PKT
+0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.17 | AstraZeneca buy | UBS AG | |
| 11.01.17 | ABB (Asea Brown Boveri) buy | Merrill Lynch & Co., Inc. | |
| 10.01.17 | Volvo (B) Hold | Société Générale Group S.A. (SG) | |
| 10.01.17 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 10.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 09.01.17 | Nokia buy | Deutsche Bank AG | |
| 09.01.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 09.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 09.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 09.01.17 | Volvo (B) Underweight | JP Morgan Chase & Co. | |
| 09.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 09.01.17 | Nokia buy | UBS AG | |
| 04.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 23.12.16 | AstraZeneca buy | Kepler Cheuvreux | |
| 22.12.16 | Nokia buy | UBS AG | |
| 19.12.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 19.12.16 | AstraZeneca buy | Jefferies & Company Inc. | |
| 16.12.16 | Novo Nordisk Hold | HSBC | |
| 13.12.16 | Nokia buy | Goldman Sachs Group Inc. | |
| 13.12.16 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 13.12.16 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 12.12.16 | Volvo (B) Equal-Weight | Morgan Stanley | |
| 12.12.16 | Ericsson (Telefon L.M.Ericsson) (B) Equal-Weight | Morgan Stanley | |
| 12.12.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.12.16 | AstraZeneca buy | Deutsche Bank AG | |
| 12.12.16 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 09.12.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.12.16 | Nokia overweight | JP Morgan Chase & Co. | |
| 07.12.16 | AstraZeneca buy | Deutsche Bank AG | |
| 07.12.16 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 06.12.16 | Novo Nordisk buy | UBS AG | |
| 02.12.16 | Volvo (B) Equal-Weight | Morgan Stanley | |
| 01.12.16 | Volvo (B) Sell | Goldman Sachs Group Inc. | |
| 01.12.16 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 30.11.16 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 30.11.16 | AstraZeneca buy | Deutsche Bank AG | |
| 30.11.16 | Novo Nordisk Neutral | Citigroup Corp. | |
| 30.11.16 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. |